Cedars-Sinai signs on to test prostate cancer patients with Decipher Prostate Cancer Classifier under innovative data sharing program between physicians from leading cancer centers San Diego, October 13, 2015 – GenomeDx Biosciences today announced that Cedars-Sinai has partnered with the company on the Decipher® Genomics Resource Information Database (Decipher GRIDTM), a clinical genomics data sharing […]
Category: Press Releases
Centers for Medicare and Medicaid Services Publishes Draft Coverage Decision to Reimburse the Decipher® Test for Intermediate & High Risk Prostate Cancer
San Diego, CA – Oct. 16, 2014 – GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been published by the Centers for Medicare and Medicaid Services (CMS) describing a coverage and payment policy for use of the Decipher test in men who have undergone radical […]
GenomeDx Adds a National PPO to Make Available Decipher® Prostate Cancer Test
San Diego, September 25, 2014 – GenomeDx Biosciences today announced that it has entered into a contractual agreement with MultiPlan, Inc. for diagnostic laboratory testing. The agreement includes GenomeDx Biosciences’ participation in the MultiPlan Network, expanding access to the Decipher® Prostate Cancer Classifier to health plan members who access the more than 500,000 providers participating […]